Tax Provision - Protagonist Therapeutics Inc (NASDAQ:PTGX) - Alpha Spread

Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 45.92 USD 2.57% Market Closed
Market Cap: 2.7B USD
Have any thoughts about
Protagonist Therapeutics Inc?
Write Note

Protagonist Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Protagonist Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Protagonist Therapeutics Inc
NASDAQ:PTGX
Tax Provision
-$2.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Tax Provision
-$1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-3%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$506m
CAGR 3-Years
32%
CAGR 5-Years
27%
CAGR 10-Years
13%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$395m
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$704.6m
CAGR 3-Years
-19%
CAGR 5-Years
-30%
CAGR 10-Years
-62%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$265.5m
CAGR 3-Years
36%
CAGR 5-Years
-27%
CAGR 10-Years
4%

See Also

What is Protagonist Therapeutics Inc's Tax Provision?
Tax Provision
-2.7m USD

Based on the financial report for Jun 30, 2024, Protagonist Therapeutics Inc's Tax Provision amounts to -2.7m USD.

Back to Top